...
首页> 外文期刊>The journal of Tehran Heart Center. >Intramural Esophageal Dissection: A Rare Cause of Acute Chest Pain after Percutaneous Coronary Intervention
【24h】

Intramural Esophageal Dissection: A Rare Cause of Acute Chest Pain after Percutaneous Coronary Intervention

机译:壁内食管解剖:经皮冠状动脉介入治疗后急性胸痛的罕见原因

获取原文
           

摘要

Intramural esophageal dissection is a condition that typically presents with chest pains and may be associated with hematemesis, odynophagia, and hematemesis. The role of antiplatelet/anticoagulant agents in the development of intramural esophageal hematoma is controversial. The management of intramural esophageal dissection is generally conservative with low mortality and morbidity. The case described here is a 66-year-old woman who presented with chest pains, odynophagia, and dysphagia 1 month after percutaneous coronary intervention while taking ASA (80 mg daily) and clopidogrel (75 mg daily) for dual antiplatelet therapy. The patient was diagnosed as intramural esophageal dissection and underwent successful conservative medical management. The relative contribution of dual antiplatelet therapy with ASA and clopidogrel after percutaneous coronary intervention in this case is, albeit uncertain, a possibility.
机译:壁内食管夹层是典型的胸痛症状,可能与呕血,吞咽痛和呕血有关。抗血小板/抗凝剂在壁内食管血肿发展中的作用是有争议的。壁内食管夹层的处理通常是保守的,死亡率和发病率低。此处描述的病例是一名66岁的女性,在经皮冠状动脉介入治疗1个月后出现胸痛,吞咽困难和吞咽困难,同时服用ASA(每天80 mg)和氯吡格雷(每天75 mg)进行双重抗血小板治疗。该患者被诊断为壁内食管夹层并接受了成功的保守药物治疗。在这种情况下,经皮冠状动脉介入治疗后,ASA和氯吡格雷双重抗血小板治疗的相对贡献是可能的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号